These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 25407488

  • 1. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
    Shen F, Cai WS, Feng Z, Li JL, Chen JW, Cao J, Xu B.
    Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.
    Liu X, Li J, Yu Z, Li J, Sun R, Kan Q.
    Oncol Res; 2017 Mar 13; 25(3):427-435. PubMed ID: 27697092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.
    Breast Cancer Res; 2012 May 14; 14(3):R77. PubMed ID: 22583478
    [Abstract] [Full Text] [Related]

  • 7. MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.
    Hao Y, Zhang S, Sun S, Zhu J, Xiao Y.
    Biomed Pharmacother; 2016 May 14; 80():121-126. PubMed ID: 27133048
    [Abstract] [Full Text] [Related]

  • 8. Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.
    Wu GG, Li WH, He WG, Jiang N, Zhang GX, Chen W, Yang HF, Liu QL, Huang YN, Zhang L, Zhang T, Zeng XC.
    PLoS One; 2014 May 14; 9(2):e88796. PubMed ID: 24558429
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
    He H, Liao X, Yang Q, Liu Y, Peng Y, Zhong H, Yang J, Zhang H, Yu Z, Zuo Y, Guan C, Xu Z.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818809993. PubMed ID: 30381030
    [Abstract] [Full Text] [Related]

  • 10. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K, Jin J, Zhao J, Song J, Song H, Li D, Maskey N, Zhao B, Wu C, Xu H, Fang L.
    Int J Oncol; 2016 May 01; 48(5):1997-2006. PubMed ID: 26934863
    [Abstract] [Full Text] [Related]

  • 11. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
    Liang HL, Hu AP, Li SL, Xie JP, Ma QZ, Liu JY.
    Asian Pac J Cancer Prev; 2015 May 01; 16(6):2397-402. PubMed ID: 25824771
    [Abstract] [Full Text] [Related]

  • 12. miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7.
    Sulidankazha C, Han W, He T, Lin H, Cheng K, Nie X, Chen Q.
    J Healthc Eng; 2022 May 01; 2022():2240605. PubMed ID: 35222878
    [Abstract] [Full Text] [Related]

  • 13. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.
    Han L, Wang W, Ding W, Zhang L.
    J Cell Mol Med; 2017 Sep 01; 21(9):2000-2008. PubMed ID: 28266181
    [Abstract] [Full Text] [Related]

  • 14. MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression.
    Ying X, Li-ya Q, Feng Z, Yin W, Ji-hong L.
    Biomed Pharmacother; 2015 Apr 01; 71():64-9. PubMed ID: 25960217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor.
    Gao B, Hao S, Tian W, Jiang Y, Zhang S, Guo L, Zhao J, Zhang G, Yan J, Luo D.
    J Gene Med; 2017 Dec 01; 19(12):. PubMed ID: 27813254
    [Abstract] [Full Text] [Related]

  • 20. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X, Zhao Y, Wang B.
    Oncol Rep; 2015 Oct 01; 34(4):2188-94. PubMed ID: 26238950
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.